As a certified Medicare Qualified Entity (QE), Blue Health Intelligence® (BHI®) produces a publicly available report assessing national quality measures using data from Medicare and Blue Cross Blue Shield commercial claims data. In this report, we examine the relationships between preventable diabetes and hypertension admission rates and socioeconomic status (SES) measures to inform the potential of improved access to preventive …
Transparency Analytics FAQ
Get the answers to the most frequently asked questions about the Transparency in Coverage rule, machine-readable files, and our Transparency Analytics solution.
QE Report 2021: Examining the relationship between socioeconomic factors and preventable diabetes- and hypertension-related inpatient admissions
As a certified national Qualified Entity (QE), BHI combines Medicare fee-for-service data with our own rich set of commercial claims data from more than 234 million individuals to research and report on the quality and delivery of care in the U.S. Our first QE report focuses on diabetes due to its increasing prevalence and ability to be effectively managed if …
Q&A: Enhanced Release of Whyzen Analytics Uses Guided Pathways to Highlight Key Findings
Kevin O’Mara, Vice President, Product Management, and Michele Heeter, Senior Director, Product Learning and Communication, discuss how BHI has reimagined Whyzen Analytics, our employer analytics and reporting solution, to help users identify and address healthcare cost, utilization, quality, and risk concerns before they escalate.
Blue Health Intelligence Offers Comprehensive Benchmarking Solutions
The November 2021 issue of Care Analytic News profiled two benchmarking resources from Blue Health Intelligence® (BHI®): the Whyzen™ National Benchmark Module (NBM) and the Customized Benchmarking Data solution.
Enhanced Whyzen™ Analytics Platform Drives Users to Most Valuable Insights
Care Analytic News showcased enhancements that Blue Health Intelligence® made to its Whyzen™ Analytics platform. The article highlights how new analytic pathways and a more intuitive interface are guiding healthcare stakeholders directly to key cost savings and care improvement opportunities.
Q&A: National Benchmarking Module Unlocks Insights Into Healthcare Costs and Utilization
In our latest Q&A, Carolyn Jevit, senior product director, discusses how BHI’s National Benchmarking Module (NBM) uses data to provide health plans and their employer customers with a deeper understanding of cost and utilization improvement opportunities at national, regional, plan, and account levels.
Q&A: The Importance of REL Data in Achieving Health Equity
Almost all commercial health plans are seeking to address health disparities, but few have the reliable and widespread race, ethnicity, and language (REL) data needed. Learn how, in the absence of self-reported data, Plans can continue to make progress.
Study: Telehealth Consults Increased Over 50-Fold During First Phase of Pandemic
An article in Care Analytic News discusses the findings from a recent study co-authored by researchers at the Johns Hopkins Bloomberg School of Public Health and Blue Health Intelligence®. The study found that telehealth consults among privately insured working-age patients accounted for almost 24 percent of outpatient consults with health care providers during the early phase of the pandemic, March …
Using BHI data to assess the impact of COVID-19 on telehealth utilization
The explosive growth of telehealth has been discussed extensively in the past year. To provide even greater insights into the nature of this COVID-19 driven-trend, BHI studied our conformed national medical claims data set, comprised of more than 22 billion claims that represent 217 million unique lives, to unearth different telehealth insights.